feed,title,long_url,short_url
MedRxiv,Quantifying selection bias due to unobserved patients in pharmacoepidemiologic studies of severe COVID-19 cohorts,https://medrxiv.org/cgi/content/short/2025.07.24.25332123v1?rss=1,
MedRxiv,A statistical immune correlates of protection model for predicting efficacy from neutralizing antibody titers to establish immunobridging of monoclonal antibodies for prevention of COVID-19,https://medrxiv.org/cgi/content/short/2025.07.24.25332145v1?rss=1,
MedRxiv,Immunobridging Analysis of Pemivibart for the Treatement of COVID-19 - A Therapeutic Gap for the Immune Compromised Remains,https://medrxiv.org/cgi/content/short/2025.07.23.25332095v1?rss=1,
